miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis

Recent studies have shown that miR-564 is closely related to the development of various tumors, including breast cancer, lung cancer and glioma. However, few studies have examined miR-564 in hepatocellular carcinoma (HCC). Here, we demonstrated that miR-564 expression in HCC tissues was lower than t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chaojie, Xu, Yingchen, Ge, Hua, Xing, Bingchen, Li, Guanqun, Li, Guangming, Wu, Jixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746087/
https://www.ncbi.nlm.nih.gov/pubmed/29296185
http://dx.doi.org/10.18632/oncotarget.22504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746087/
https://www.ncbi.nlm.nih.gov/pubmed/29296185
http://dx.doi.org/10.18632/oncotarget.22504

Ejemplares similares